A Study in Healthy Men to Test the Influence of BI 1358894 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood

NCT04099732 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rosuvastatin
DRUG: BI 1358894
DEVICE: Dabigatran etexilate

Sponsor

Boehringer Ingelheim